CELF2

CUGBP Elav-like family member 2 · O95319 · CELF2 on Sugi Atlas →

0 patent compounds predicted against CELF2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CELF2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer PHASE1/PHASE2COMPLETED
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer PHASE1/PHASE2COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer PHASE1COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer PHASE1COMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Novel Biophotonics Methodology for Colon Cancer Screening nanCOMPLETED
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
Amyotrophic Lateral Sclerosis (ALS) Families Project nanRECRUITING
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Williams Syndrome (WS) and Supravalvar Aortic Stenosis (SVAS) DNA and Tissue Bank nanCOMPLETED
Identification of New FTLD Genes nanUNKNOWN
A Study of the Genetic Analysis of Brain Disorders nanCOMPLETED
The Influence of Genetic Variations in ELAPOR1 or ELAPOR2 on Insulin Secretion and Glucose Regulation in Humans nanUNKNOWN
Exome Analysis in Hearing Impaired Patients nanUNKNOWN
Maternal Genes and Epimutations: Beckwith-Wiedemann Syndrome & Reproductive Risks nanRECRUITING
Genetic Basis of Non Syndromic Congenital Diaphragmatic Hernia nanCOMPLETED
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives nanUNKNOWN
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus nanACTIVE_NOT_RECRUITING
Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases nanCOMPLETED
Genetic Analysis of Hereditary Disorders of Hearing and Balance nanCOMPLETED
Risk Factors for the Development of Celiac Disease in Genetically Predisposed Children nanUNKNOWN
Collection of Blood Samples for DNA in Motor Neuron Disease nanCOMPLETED
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development nanCOMPLETED
Improving Genetic Counseling for Patients With Spina Bifida Using Next Generation Sequencing nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Mapping Novel Disease Genes for Dilated Cardiomyopathy nanCOMPLETED
Investigating the Genetic Basis of Pseudoexfoliation Syndrome, Angle-closure Glaucoma and Primary Open-angle Glaucoma nanRECRUITING
Child Development and Genetic Biomarkers(II): Gene Verification and Data Integration nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a CELF2 binder may also engage these)

ProteinNameSimilarity
Q792H5 1.000 Q792H5 →
A4IIM2 1.000 A4IIM2 →
Q5R8Y8 1.000 Q5R8Y8 →
Q9Z0H4 1.000 Q9Z0H4 →
Q7T2T1 1.000 Q7T2T1 →
P28659 0.999 P28659 →
Q6P0B1 0.997 Q6P0B1 →
Q5R995 0.994 Q5R995 →
Q28HE9 0.994 Q28HE9 →
Q4QQT3 0.994 Q4QQT3 →
Q7ZXE2 0.993 Q7ZXE2 →
Q92879 0.991 Q92879 →
Q6PF35 0.991 Q6PF35 →
Q5F3T7 0.988 Q5F3T7 →
O57406 0.985 O57406 →
Q9IBD0 0.983 Q9IBD0 →
Q7ZWM3 0.958 Q7ZWM3 →
Q4R535 0.957 Q4R535 →
Q91579 0.957 Q91579 →
Q2PFW9 0.953 Q2PFW9 →
Q80WA4 0.953 Q80WA4 →
Q6DGV1 0.953 Q6DGV1 →
Q5NVC8 0.945 Q5NVC8 →
P51513 0.945 P51513 →
Q9JKN6 0.943 Q9JKN6 →
A0A1W2P872 0.940 A0A1W2P872 →
Q3ZBP3 0.939 Q3ZBP3 →
Q9UNW9 0.939 Q9UNW9 →
Q9BZC1 0.938 Q9BZC1 →
Q08E07 0.937 Q08E07 →